Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors.

<h4>Background</h4>Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cancer. One of the processes disturbed in this cancer type is alternative splicing, although phenomena underlying these disturbances remain unknown. Alternative splicing consists of selective remo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Agnieszka Piekielko-Witkowska, Hanna Wiszomirska, Anna Wojcicka, Piotr Poplawski, Joanna Boguslawska, Zbigniew Tanski, Alicja Nauman
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a85875f707584bf3a86ea45229d084f6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a85875f707584bf3a86ea45229d084f6
record_format dspace
spelling oai:doaj.org-article:a85875f707584bf3a86ea45229d084f62021-11-18T07:02:44ZDisturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors.1932-620310.1371/journal.pone.0013690https://doaj.org/article/a85875f707584bf3a86ea45229d084f62010-10-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21082031/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cancer. One of the processes disturbed in this cancer type is alternative splicing, although phenomena underlying these disturbances remain unknown. Alternative splicing consists of selective removal of introns and joining of residual exons of the primary transcript, to produce mRNA molecules of different sequence. Splicing aberrations may lead to tumoral transformation due to synthesis of impaired splice variants with oncogenic potential. In this paper we hypothesized that disturbed alternative splicing in ccRCC may result from improper expression of splicing factors, mediators of splicing reactions.<h4>Methodology/principal findings</h4>Using real-time PCR and Western-blot analysis we analyzed expression of seven splicing factors belonging to SR proteins family (SF2/ASF, SC35, SRp20, SRp75, SRp40, SRp55 and 9G8), and one non-SR factor, hnRNP A1 (heterogeneous nuclear ribonucleoprotein A1) in 38 pairs of tumor-control ccRCC samples. Moreover, we analyzed splicing patterns of five genes involved in carcinogenesis and partially regulated by analyzed splicing factors: RON, CEACAM1, Rac1, Caspase-9, and GLI1.<h4>Conclusions/significance</h4>We found that the mRNA expression of splicing factors was disturbed in tumors when compared to paired controls, similarly as levels of SF2/ASF and hnRNP A1 proteins. The correlation coefficients between expression levels of specific splicing factors were increased in tumor samples. Moreover, alternative splicing of five analyzed genes was also disturbed in ccRCC samples and splicing pattern of two of them, Caspase-9 and CEACAM1 correlated with expression of SF2/ASF in tumors. We conclude that disturbed expression of splicing factors in ccRCC may possibly lead to impaired alternative splicing of genes regulating tumor growth and this way contribute to the process of carcinogenesis.Agnieszka Piekielko-WitkowskaHanna WiszomirskaAnna WojcickaPiotr PoplawskiJoanna BoguslawskaZbigniew TanskiAlicja NaumanPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 5, Iss 10, p e13690 (2010)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Agnieszka Piekielko-Witkowska
Hanna Wiszomirska
Anna Wojcicka
Piotr Poplawski
Joanna Boguslawska
Zbigniew Tanski
Alicja Nauman
Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors.
description <h4>Background</h4>Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cancer. One of the processes disturbed in this cancer type is alternative splicing, although phenomena underlying these disturbances remain unknown. Alternative splicing consists of selective removal of introns and joining of residual exons of the primary transcript, to produce mRNA molecules of different sequence. Splicing aberrations may lead to tumoral transformation due to synthesis of impaired splice variants with oncogenic potential. In this paper we hypothesized that disturbed alternative splicing in ccRCC may result from improper expression of splicing factors, mediators of splicing reactions.<h4>Methodology/principal findings</h4>Using real-time PCR and Western-blot analysis we analyzed expression of seven splicing factors belonging to SR proteins family (SF2/ASF, SC35, SRp20, SRp75, SRp40, SRp55 and 9G8), and one non-SR factor, hnRNP A1 (heterogeneous nuclear ribonucleoprotein A1) in 38 pairs of tumor-control ccRCC samples. Moreover, we analyzed splicing patterns of five genes involved in carcinogenesis and partially regulated by analyzed splicing factors: RON, CEACAM1, Rac1, Caspase-9, and GLI1.<h4>Conclusions/significance</h4>We found that the mRNA expression of splicing factors was disturbed in tumors when compared to paired controls, similarly as levels of SF2/ASF and hnRNP A1 proteins. The correlation coefficients between expression levels of specific splicing factors were increased in tumor samples. Moreover, alternative splicing of five analyzed genes was also disturbed in ccRCC samples and splicing pattern of two of them, Caspase-9 and CEACAM1 correlated with expression of SF2/ASF in tumors. We conclude that disturbed expression of splicing factors in ccRCC may possibly lead to impaired alternative splicing of genes regulating tumor growth and this way contribute to the process of carcinogenesis.
format article
author Agnieszka Piekielko-Witkowska
Hanna Wiszomirska
Anna Wojcicka
Piotr Poplawski
Joanna Boguslawska
Zbigniew Tanski
Alicja Nauman
author_facet Agnieszka Piekielko-Witkowska
Hanna Wiszomirska
Anna Wojcicka
Piotr Poplawski
Joanna Boguslawska
Zbigniew Tanski
Alicja Nauman
author_sort Agnieszka Piekielko-Witkowska
title Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors.
title_short Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors.
title_full Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors.
title_fullStr Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors.
title_full_unstemmed Disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors.
title_sort disturbed expression of splicing factors in renal cancer affects alternative splicing of apoptosis regulators, oncogenes, and tumor suppressors.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/a85875f707584bf3a86ea45229d084f6
work_keys_str_mv AT agnieszkapiekielkowitkowska disturbedexpressionofsplicingfactorsinrenalcanceraffectsalternativesplicingofapoptosisregulatorsoncogenesandtumorsuppressors
AT hannawiszomirska disturbedexpressionofsplicingfactorsinrenalcanceraffectsalternativesplicingofapoptosisregulatorsoncogenesandtumorsuppressors
AT annawojcicka disturbedexpressionofsplicingfactorsinrenalcanceraffectsalternativesplicingofapoptosisregulatorsoncogenesandtumorsuppressors
AT piotrpoplawski disturbedexpressionofsplicingfactorsinrenalcanceraffectsalternativesplicingofapoptosisregulatorsoncogenesandtumorsuppressors
AT joannaboguslawska disturbedexpressionofsplicingfactorsinrenalcanceraffectsalternativesplicingofapoptosisregulatorsoncogenesandtumorsuppressors
AT zbigniewtanski disturbedexpressionofsplicingfactorsinrenalcanceraffectsalternativesplicingofapoptosisregulatorsoncogenesandtumorsuppressors
AT alicjanauman disturbedexpressionofsplicingfactorsinrenalcanceraffectsalternativesplicingofapoptosisregulatorsoncogenesandtumorsuppressors
_version_ 1718423997734977536